By Matthew Guarnaccia ( July 20, 2018, 5:31 PM EDT) -- Venture capital-backed Replimune Group Inc., represented by Morgan Lewis & Bockius LLP, on Friday picked up $101.5 million from its initial public offering as the cancer-focused biotechnology firm finished above its $15-per-share offer in its first day on the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.